Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature

AA Okada - Ocular immunology and inflammation, 2005 - Taylor & Francis
… with multiple agent ‘recipes’ are also considered. Immunomodulatory agents include the …
Chlorambucil may be useful in severe cases of ocular inflammation as a second-line agent, …

[HTML][HTML] Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis

F Luppi, S Cerri, B Beghè, LM Fabbri, L Richeldi - Respiratory medicine, 2004 - Elsevier
… affected by this deadly disease, and for their physicians, could come in the near future from
large randomized-controlled trials with gamma interferon or other immunomodulatory agents. …

Hospitalization for COVID‐19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: a Danish …

BM Nørgård, J Nielsen, T Knudsen… - British Journal of …, 2021 - Wiley Online Library
Aims In the Danish population, we examined whether patients treated with thiopurines,
methotrexate, systemic corticosteroids, anti‐tumour necrosis factor (TNF)‐α agents, anti‐…

[HTML][HTML] Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review

D Andaluz-Ojeda, P Vidal-Cortes, ÁA Sanz… - World Journal of …, 2022 - ncbi.nlm.nih.gov
… revealed that in many severe cases of COVID-19 the … immunomodulatory therapies in
critically ill patients. To analyze the mechanism of action of the different immunomodulatory agents

Systemic immunomodulatory therapy in severe dry eye secondary to inflammation

M Cordero-Coma, F Anzaar, L Sobrin… - Ocular Immunology and …, 2007 - Taylor & Francis
… Treatment with systemic immunomodulatory agents resulted in … We report four cases of
patients with unusually severe … and required systemic immunomodulatory therapy, resulting in …

[PDF][PDF] A Review Study on Efficacy of Immunomodulatory agents used for the Treatment of Covid-19

AU Kurya, AU Toro, UR Bello… - Asian Journal of …, 2020 - researchgate.net
… the infection was less severe and did not require ICU admission due to excessive immune
responses induced by the immune system. Potential of immunomodulatory agents such as …

Macrolides as immunomodulatory agents

PC Woo, SK Lau, KY Yuen - … Inflammatory & Anti-Allergy Agents, 2002 - ingentaconnect.com
Severe cases of both conditions often necessitate surgical treatment and steroid therapy.
However, there is a group of patients who fail these more aggressive strategies and such …

Therapeutic role of immunomodulators during the COVID-19 pandemic–a narrative review

H Al-Hajeri, F Baroun, F Abutiban… - Postgraduate …, 2022 - Taylor & Francis
… of immunomodulators can be potentially lifesaving, particularly in severe COVID-19 cases. …
, anecdotal data, and clinical cases guide current treatment strategies and limited evidence-…

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now

MA Mohammed - Frontiers in Pharmacology, 2023 - frontiersin.org
… in the case of hydroxyl-chloroquine, and liver destruction in the case of remdesivir. This
review summarizes four strategies for fighting cytokine storms and immunomodulatory deficiency …

Immunomodulatory agents for treatment of patients with inflammatory bowel disease (review safety of anti-TNF, anti-integrin, anti IL-12/23, JAK inhibition, sphingosine …

L Sattler, SB Hanauer, L Malter - Current gastroenterology reports, 2021 - Springer
… We will review the most recent safety data for the newly approved immunomodulator … In
the future, as we gain more experience with these agents, we will need to continue to evaluate …